BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38663405)

  • 1. Intrathecal gene therapy for neurologic disease in humans.
    Flotte TR
    Mol Ther; 2024 May; 32(5):1185-1186. PubMed ID: 38663405
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathecal Delivery of Viral Vectors for Gene Therapy.
    Kagiava A; Kleopa KA
    Methods Mol Biol; 2018; 1791():277-285. PubMed ID: 30006718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy revisited. In spite of problems and drawbacks, gene therapy moves forward.
    Brower V
    EMBO Rep; 2001 Dec; 2(12):1064-5. PubMed ID: 11743014
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders.
    Lonser RR; Akhter AS; Zabek M; Elder JB; Bankiewicz KS
    J Neurosurg; 2020 Jul; 134(6):1751-1763. PubMed ID: 32915526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy of nervous system diseases in children].
    Gressens P
    Arch Pediatr; 1996 Nov; 3(11):1136-8. PubMed ID: 8952780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Gene Therapies for Metabolic and Neurologic Diseases.
    Biffi A
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):869-881. PubMed ID: 28895853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological gene therapy.
    Fooks AR; Jennings AD; Doyle A; Clegg JC; Stacey GN
    Sci Prog; 1997; 80 ( Pt 2)():107-24. PubMed ID: 9263509
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
    Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
    Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal Delivery of AAV Vectors in Cynomolgus Macaques for CNS Gene Therapy and Gene Expression Analysis in Microdissected Motor Neurons.
    Borel F; Adams E; Mueller C
    Methods Mol Biol; 2019; 1937():295-303. PubMed ID: 30706405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene transfer to treat neurologic disease.
    Smith GM
    Arch Neurol; 1998 Aug; 55(8):1061-4. PubMed ID: 9708955
    [No Abstract]   [Full Text] [Related]  

  • 11. Detailed Method for Intrathecal Delivery of Gene Therapeutics by Direct Lumbar Puncture in Mice.
    Pflepsen KR; Peterson CD; Kitto KF; Vulchanova L; Wilcox GL; Fairbanks CA
    Methods Mol Biol; 2019; 1937():305-312. PubMed ID: 30706406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes virus vectors for gene therapy in the nervous system.
    Latchman DS
    Biochem Soc Trans; 1999 Dec; 27(6):847-51. PubMed ID: 10830115
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripherally delivered Adeno-associated viral vectors for spinal cord injury repair.
    Sydney-Smith JD; Spejo AB; Warren PM; Moon LDF
    Exp Neurol; 2022 Feb; 348():113945. PubMed ID: 34896114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
    Bailey RM; Rozenberg A; Gray SJ
    Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons.
    Dindot S; Piccolo P; Grove N; Palmer D; Brunetti-Pierri N
    Hum Gene Ther; 2011 Jun; 22(6):745-51. PubMed ID: 21175294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
    Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
    Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.
    Latchman DS
    J R Soc Med; 1999 Nov; 92(11):566-70. PubMed ID: 10703493
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic therapy for the nervous system.
    Bowers WJ; Breakefield XO; Sena-Esteves M
    Hum Mol Genet; 2011 Apr; 20(R1):R28-41. PubMed ID: 21429918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Gene Therapy for Targeting the CNS.
    Gombash SE; Foust KD
    Methods Mol Biol; 2016; 1382():231-7. PubMed ID: 26611590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for childhood neurological disease.
    Sahin M
    Pediatr Neurol; 2014 Nov; 51(5):595-6. PubMed ID: 25439574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.